
3.16 Delayed Data As of May 31 | ![]() Today’s Change | 1.95 Today|||52-Week Range 3.17 | +7.68% Year-to-Date |
There is no forecast data available.
The current consensus among 1 polled investment analysts is to Hold stock in PharmaCyte Biotech Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.